Lamotrigine Tablet, Extended Release shortage
To Be Discontinued 6 presentations · 1 manufacturers · first FDA posting Apr 29, 2026 · last update Apr 29, 2026
Manufacturers: Par Health, Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 29, 2026 Updated Apr 29, 2026 Discontinued Apr 29, 2026 |
| Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 29, 2026 Updated Apr 29, 2026 Discontinued Apr 29, 2026 |
| Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 29, 2026 Updated Apr 29, 2026 Discontinued Apr 29, 2026 |
| Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 29, 2026 Updated Apr 29, 2026 Discontinued Apr 29, 2026 |
| Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 29, 2026 Updated Apr 29, 2026 Discontinued Apr 29, 2026 |
| Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11) | Par Health, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 29, 2026 Updated Apr 29, 2026 Discontinued Apr 29, 2026 |